皮肤病学中的:探索其在增强肉毒素配方和临床疗效方面的新兴作用
Lacey Foster1, Jose A Foppiani2, Helen Xun1
1Division of Plastic and Reconstructive Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.
Current issues in molecular biology
|November 26, 2024
概括
可以增强皮肤健康,并可以通过提高疗效和稳定性来改善毒素治疗. 需要进一步的研究来优化.
科学领域:
- 皮肤病学 皮肤病学
- 审美医学是一种美学医学.
- 生物化学 生物化学
背景情况:
- 对于皮肤形态发生,再生和保护至关重要.
- 用于局部和全身皮肤产品.
- 它在美容医学中的作用,特别是与肉毒毒素的作用,尚未得到充分研究.
研究的目的:
- 探索在皮肤病学中的潜力,专注于肉毒素配方.
- 确定研究缺口,并指导未来对的化应用的研究.
主要方法:
- 对的皮肤功能进行文献综述.
- 对和肉毒素的现有研究和专利进行分析.
- 评估在产品稳定和治疗效果中的作用.
主要成果:
- 对皮肤健康的已知好处表明,毒素的有效性和稳定性可能会得到提高.
- 新兴专利表明有希望的-玻丁毒素配方.
- 目前对口服补充剂的研究显示,延长肉毒素效应的结果各不相同.
结论:
- 具有改善皮肤病治疗的巨大潜力,特别是在美容医学中.
- 需要进一步的研究来确定最佳的度和用于化品应用的输送方法.
- 的特性要求对传统化品制剂之外的更广泛的治疗用途进行研究.
相关概念视频
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
654
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
654
Skeletal Muscle Relaxants: Therapeutic Uses
464
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
464
Depolarizing Blockers: Pharmocokinetics
308
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
308
Depolarizing Blockers: Mechanism of Action
1.4K
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
1.4K
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
392
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
392


